Type 1 Diabetes Trial, Recruiting NCT07621445 Sponsor: Second Xiangya Hospital of Central South University Condition: Type 1 Diabetes
Back to Type 1 Diabetes

Type 1 Diabetes Trial, Recruiting

NCT07621445
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People of any gender may be considered.
  • People between the ages of 14 and 50 years old.
  • People who have been diagnosed with diabetes within the last year, where the diagnosis was confirmed by blood sugar or HbA1c test results meeting specific levels (confirm with trial site for exact values).
  • People whose type of diabetes (for example, whether it is Type 1 or Type 2) has not yet been clearly determined by their doctors.

Who may not be able to join:

  • People whose pancreas produces very little insulin, as shown by a specific blood test result (C-peptide peak below a certain level — confirm with trial site).
  • People whose diabetes is related to pregnancy, a known genetic condition, a pancreatic disease such as cystic fibrosis, or was caused by a medication or chemical.
  • People who have been on long-term hormone or immune-suppressing medications.
  • Women who are pregnant or currently breastfeeding.
  • People who have cancer or serious heart, liver, or kidney disease at the same time.
  • People whose life expectancy is estimated to be less than 3 years.
  • People who have a mental health condition or another reason that would make it difficult to take part in the study.
  • People currently experiencing a serious diabetes-related emergency involving acid build-up in the blood (diabetic ketoacidosis).
  • People currently dealing with a serious infection, high fever, significant injury, or recent major surgery.
  • People whose medical records are missing important health information needed for the study.
  • People whom the research team considers unsuitable for participation for any other reason.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Second Xiangya Hospital of Central South University
Registry
ClinicalTrials.gov
Start date
27 October 2025
Est. completion
31 December 2029

Where this trial is recruiting

🇨🇳 China

Primary endpoints

C-peptide

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov